IDEXX Laboratories, Inc.

NasdaqGS:IDXX

Sector

🛒 Consumer Staples

Industries

🩺 Medical Instruments

🧼 Cleaning Supplies

🔬 Clinical Trials

🏬 Consumer Packaged Goods

🐶 Pet Food

Location

United States

Market Cap

USD 42.66 B

Share Price

USD 527.78

Avg Daily Volume

829,026

Change (1 day)

-0.49%

Change (1 year)

8.02%

Change (YTD)

27.66%

IDEXX Laboratories, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2025: USD 47.93

IDEXX Laboratories, Inc. Revenue Per Share is USD 47.93 for the Trailing 12 Months (TTM) ending March 31, 2025, a 6.93% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.

IDEXX Laboratories, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 44.83, a 8.80% change year over year.
IDEXX Laboratories, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 41.20, a 6.86% change year over year.
IDEXX Laboratories, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 38.56, a 15.16% change year over year.
IDEXX Laboratories, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 33.48, a 17.07% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Revenue Per Share	Free Cash Flow Per Share	Dividend Per Share	Debt to Equity Ratio

NasdaqGS: IDXX

IDEXX Laboratories, Inc.

CEO	Mr. Jonathan J. Mazelsky
IPO Date	June 21, 1991
Location	United States
Headquarters	One IDEXX Drive
Employees	11,000
Sector	🛒 Consumer Staples
Industries Medical Instruments 🧼 Cleaning Supplies 🔬 Clinical Trials 🏬 Consumer Packaged Goods 🐶 Pet Food

Description

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.